News Search Results
Sep 15, 2025, 10:45 ET Immunohistochemistry Market worth US$5.14 billion by 2030 with 7.6% CAGR | MarketsandMarkets™
Technologies, Inc. (US), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (US), Bio-Techne (US), Becton, Dickinson and Company (US), Takara Bio Inc. (Japan), PHC Holdings Corporation (Japan),
More news about: MarketsandMarkets
Sep 09, 2025, 07:00 ET ScaleReady Awards G-Rex® Grants to Support Cell and Gene Therapy Manufacturing in California
G-Rex® device at a time. About Bio-Techne CorporationBio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne, in partnership with Wilson
More news about: Bio-Techne Corporation
Sep 04, 2025, 11:42 ET MSC-Specific Cell Culture Medium Market to Reach USD 4.1 Billion by 2035, with CAGR 11.6% Driven by Regenerative Medicine and Stem Cell Therapy Growth
ScientificLonza GroupMerck KGaASartorius AGCorning IncorporatedPromoCell GmbHSTEMCELL TechnologiesBio-Techne CorporationFUJIFILM Irvine ScientificHiMedia LaboratoriesTo Know an Additional List of Key Players, Request Here
More news about: Vantage Market Research
Aug 27, 2025, 07:00 ET Bio-Techne to Present at Upcoming Investor Conferences
https://investors.bio-techne.com/ir-calendar. About Bio-TechneBio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into
More news about: Bio-Techne Corporation
Aug 26, 2025, 17:46 ET Global Digital Biomarkers Market Anticipating Remarkable Growth at a CAGR of ~17% by 2032 | DelveInsight
including Abbott, Merck KGaA, Quanterix, Bio-Rad Laboratories, Inc., Banyan Biomarkers, Inc., Quanterix, Thermo Fisher Scientific, Fujirebio, Bio-Techne, ADx NeuroSciences NV, F. Hoffmann-La Roche Ltd., BIOMÉRIEUX, Siemens Healthineers, Quibim, C₂N Diagnostics, among others.
More news about: DelveInsight Business Research, LLP
Aug 14, 2025, 07:00 ET ScaleReady Announces Award of a G-Rex® Grant to the Gates Institute's Translational Sciences Laboratory
G-Rex® device at a time. About Bio-Techne CorporationBio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne, in partnership with Wilson
More news about: Bio-Techne Corporation
Aug 06, 2025, 06:30 ET BIO-TECHNE DECLARES DIVIDEND
considered by the Board of Directors on a quarterly basis. Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological
More news about: Bio-Techne Corporation
Aug 06, 2025, 06:30 ET Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
included in this press release. "Bio-Techne delivered a solid fourth quarter that was in-line with our expectations, despite ongoing market uncertainty," said Kim Kelderman, President and Chief Executive Officer of Bio-Techne. "We achieved strong performance in our
More news about: Bio-Techne Corporation
Aug 05, 2025, 16:30 ET Bio-Techne Announces Exosome Diagnostics Divestiture
emphasis on these statements. About Bio-TechneBio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into
More news about: Bio-Techne Corporation
Aug 05, 2025, 10:45 ET Cell Culture Market to Reach USD 71.1 Billion by 2032, Says SkyQuest Technology Consulting
SELonzaGetinge AB (Sweden)Agilent Technologies Inc.HiMedia LaboratoriesBio-TechneMiltenyi BiotecSTEMCELL TechnologiesSolida Biotech GmbHCaisson Labs Inc.PromoCell GmbHInvivoGenPan-BiotechSecure
More news about: SkyQuest Technology
Aug 05, 2025, 07:00 ET ScaleReady Announces a G-Rex® Grant has been awarded to Sidra Medicine
a time. About Bio-Techne CorporationBio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne, in partnership with Wilson
More news about: Bio-Techne Corporation
Jul 31, 2025, 10:30 ET Cell Culture Market worth US$50.69 billion by 2030 with 11.2% CAGR | MarketsandMarkets™
(Scotland), Meissner Filtration Products Inc. (US), Adolf Kühner AG (Switzerland), Bio-Techne (US), Advancion Corporation (US), and BioSpherix, Ltd. (US). Thermo Fisher Scientific Inc. (US): Thermo Fisher Scientific is
More news about: MarketsandMarkets
Jul 31, 2025, 07:00 ET ScaleReady announces multiple G-Rex® Grants have been awarded to investigators at University of Minnesota's Center for Genome Engineering
G-Rex® device at a time. About Bio-Techne CorporationBio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne, in partnership with Wilson
More news about: Bio-Techne Corporation
Jul 28, 2025, 08:30 ET Global Momentum and Validation Grows at AAIC for ALZpath Proprietary pTau217 Antibody Use in Alzheimer's Disease Research, Diagnosis, and Treatment
treatment and monitoring. Through licensing agreements with industry leaders – including Beckman Coulter Diagnostics, Roche, Alamar Biosciences, Bio-techne, and Quanterix – ALZpath is accelerating the development of new medicines and expanding access to early diagnosis and monitoring. Additionally, ALZpath
More news about: ALZpath, Inc.
Jul 25, 2025, 12:13 ET Proteomics Market to Expand Rapidly, with 13% CAGR forecast Through 2030
include: AGILENT TECHNOLOGIES INC. ARRAYIT CORP. BIO-RAD LABORATORIES INC. BIO-TECHNE BRUKER CREATIVE PROTEOMICS DANAHER CORP. JEOL LTD. MERCK KGAA PROMEGA
More news about: BCC Research LLC
Jul 25, 2025, 09:07 ET Spear Bio Launches Next Generation Ultrasensitive Immunoassay Solution SPEAR UltraDetect™ to Transform Neurodegenerative Disease Research
Bio-Techne to distribute SPEAR UltraDetect immunoassays globally.
More news about: Spear Bio
Jul 17, 2025, 07:00 ET Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results
Saturday, September 6, 2025. About Bio-TechneBio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into
More news about: Bio-Techne Corporation
Jul 15, 2025, 07:00 ET Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection
Learn more about Spear Bio and Bio-Techne About Bio-Techne Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific
More news about: Bio-Techne Corporation
Jul 14, 2025, 07:00 ET Bio-Techne's Simple Western™ Technology Utilized in Recent FDA Approval of ZEVASKYN™ Cell-Based Gene Therapy
therapy for patients with RDEB." About Bio-Techne Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into
More news about: Bio-Techne Corporation
Jul 08, 2025, 10:30 ET $2.35 Billion by 2030: Why In Situ Hybridization Is Revolutionizing Molecular Diagnostics | MarketsandMarkets™
biology tools.Abbott (US): Dominant in ISH probes for oncology and cytogenetics under the VYSIS brand.Bio-Techne (US): RNAscope portfolio expansion to 70,000+ probes position it as a spatial transcriptomics leader.Thermo Fisher
More news about: MarketsandMarkets
Jul 01, 2025, 11:23 ET Global Market for Media, Sera, and Reagents in Biotechnology to Reach $9.3 Billion by 2029
North America holds the largest share of the market. Market leaders include: ATCCBDBIO-TECHNEBIOWESTCORNING INC.DANAHER CORP.FUJIFILM IRVINE SCIENTIFICLONZAMERCK KGAAMILTENYI BIOTECPROMOCELL
More news about: BCC Research LLC
Jun 30, 2025, 10:15 ET IVD Assay Development Market to Reach $9.15 Billion by 2032, Growing at a CAGR of 8.1% from 2025, Says Meticulous Research®
development market include Thermo Fisher Scientific Inc. (U.S.), Avioq, Inc. (U.S.), Creative Biolabs, Inc (U.S.), Maxim Biomedical, Inc. (U.S.), Bio-Techne Corporation (U.S.), Merck KGaA (Germany), PeploBio Ltd (U.K.), ICON plc (Ireland),
More news about: Meticulous Market Research Pvt. Ltd.
Jun 24, 2025, 07:00 ET Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development
assays on the Maurice system. About Bio-Techne Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into
More news about: Bio-Techne Corporation
Jun 10, 2025, 10:15 ET Exosome Research Market worth US$480.6 million by 2030 with 17.5% CAGR | MarketsandMarkets™
exosome research arena, showcasing a dual focus on environmental sustainability and advancements in technological efficiency. Bio-Techne (US) Bio-Techne solidified its status as a significant player in the liquid biopsy diagnostics arena following its acquisition of Exosome Diagnostics
More news about: MarketsandMarkets
Jun 10, 2025, 07:00 ET ScaleReady Announces a G-Rex® Grant has been awarded to Immuneel Therapeutics
G-Rex® device at a time. About Bio-Techne CorporationBio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne, in partnership with Wilson
More news about: Bio-Techne Corporation